Medical System Network Co., Ltd. (TYO:4350)
Japan · Delayed Price · Currency is JPY 535.00
-11.00 (-2.01%)
Feb 13, 2026, 3:30 PM JST
Medical System Network Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
| 129,176 | 122,387 | 115,361 | 109,551 | 106,685 | 104,257 | |
Revenue Growth (YoY) | 6.69% | 6.09% | 5.30% | 2.69% | 2.33% | -0.94% |
Cost of Revenue | 76,456 | 71,651 | 67,435 | 63,629 | 62,256 | 61,844 |
Gross Profit | 52,720 | 50,736 | 47,926 | 45,922 | 44,429 | 42,413 |
Selling, General & Admin | 49,766 | 40,555 | 37,448 | 36,511 | 34,508 | 33,164 |
Other Operating Expenses | - | 7,027 | 6,645 | 6,247 | 6,068 | 5,818 |
Operating Expenses | 49,766 | 47,582 | 44,093 | 42,758 | 40,576 | 38,982 |
Operating Income | 2,954 | 3,154 | 3,833 | 3,164 | 3,853 | 3,431 |
Interest Expense | -313 | -278 | -288 | -277 | -183 | -215 |
Interest & Investment Income | 12 | 7 | 4 | 5 | 6 | 9 |
Other Non Operating Income (Expenses) | 206 | 277 | 274 | 462 | 638 | 254 |
EBT Excluding Unusual Items | 2,794 | 3,160 | 3,823 | 3,354 | 4,314 | 3,479 |
Gain (Loss) on Sale of Investments | - | - | 78 | - | 112 | 898 |
Gain (Loss) on Sale of Assets | 9 | 332 | 13 | 7 | -9 | -17 |
Asset Writedown | -684 | -767 | -445 | -304 | -411 | -370 |
Other Unusual Items | -6 | -2 | -20 | -39 | 7 | -23 |
Pretax Income | 2,027 | 2,723 | 3,449 | 3,018 | 4,013 | 3,967 |
Income Tax Expense | 1,158 | 1,424 | 1,579 | 1,389 | 1,624 | 1,769 |
Earnings From Continuing Operations | 869 | 1,299 | 1,870 | 1,629 | 2,389 | 2,198 |
Minority Interest in Earnings | -42 | -37 | -10 | -19 | 5 | - |
Net Income | 827 | 1,262 | 1,860 | 1,610 | 2,394 | 2,198 |
Net Income to Common | 827 | 1,262 | 1,860 | 1,610 | 2,394 | 2,198 |
Net Income Growth | -48.70% | -32.15% | 15.53% | -32.75% | 8.92% | - |
Shares Outstanding (Basic) | 29 | 29 | 30 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 29 | 29 | 30 | 30 | 30 | 30 |
Shares Change (YoY) | -0.44% | -2.80% | -0.36% | 0.03% | -0.47% | -0.22% |
EPS (Basic) | 28.29 | 43.18 | 61.86 | 53.35 | 79.35 | 72.51 |
EPS (Diluted) | 28.29 | 43.18 | 61.86 | 53.35 | 79.35 | 72.51 |
EPS Growth | -48.47% | -30.20% | 15.95% | -32.77% | 9.44% | - |
Free Cash Flow | - | 1,751 | 5,863 | 3,600 | 2,076 | 3,830 |
Free Cash Flow Per Share | - | 59.91 | 194.98 | 119.29 | 68.81 | 126.34 |
Dividend Per Share | 12.000 | 12.000 | 12.000 | 12.000 | 11.000 | 10.000 |
Dividend Growth | - | - | - | 9.09% | 10.00% | - |
Gross Margin | 40.81% | 41.45% | 41.54% | 41.92% | 41.64% | 40.68% |
Operating Margin | 2.29% | 2.58% | 3.32% | 2.89% | 3.61% | 3.29% |
Profit Margin | 0.64% | 1.03% | 1.61% | 1.47% | 2.24% | 2.11% |
Free Cash Flow Margin | - | 1.43% | 5.08% | 3.29% | 1.95% | 3.67% |
EBITDA | 6,556 | 6,568 | 6,996 | 6,121 | 6,708 | 6,426 |
EBITDA Margin | 5.08% | 5.37% | 6.06% | 5.59% | 6.29% | 6.16% |
D&A For EBITDA | 3,602 | 3,414 | 3,163 | 2,957 | 2,855 | 2,995 |
EBIT | 2,954 | 3,154 | 3,833 | 3,164 | 3,853 | 3,431 |
EBIT Margin | 2.29% | 2.58% | 3.32% | 2.89% | 3.61% | 3.29% |
Effective Tax Rate | 57.13% | 52.30% | 45.78% | 46.02% | 40.47% | 44.59% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.